Penn State scientists have discovered a novel drug target and have rescued functional deficits in human nerve cells derived from patients with Rett Syndrome, a severe form of autism-spectrum disorder. The research, led by Gong Chen, professor of biology and the Verne M. Willaman Chair in Life Sciences at Penn State, could lead to a new treatment for Rett Syndrome and other forms of autism-spectrum disorders. A paper describing the research was published on Jan. 4, 2016, in the online Early Edition of the journal Proceedings of the National Academy of Sciences.
“The most exciting part of this research is that it directly uses human neurons that originated from Rett Syndrome patients as a clinically-relevant disease model to investigate the underlying mechanism,” said Chen. “Therefore, the new drug target discovered in this study might have direct clinical implication in the treatment of Rett Syndrome and potentially for other autism-spectrum disorders as well.”
The researchers differentiated stem cells derived from the skin cells of patients with Rett Syndrome into nerve cells that could be studied in the laboratory. These nerve cells carry a mutation in the gene MECP2, and such gene mutations are believed to be the cause of most cases of Rett Syndrome. The researchers discovered that these nerve cells lacked an important molecule, KCC2, that is critical to normal nerve cell function and brain development.
“KCC2 controls the function of the neurotransmitter GABA at a critical time during early brain development,” Chen said. “Interestingly, when we put KCC2 back into Rett neurons, the GABA function returns to normal. We therefore think that increasing KCC2 function in individuals with Rett Syndrome may lead to a potential new treatment.”
The researchers also showed that treating diseased nerve cells with insulin-like growth factor 1 (IGF1) elevated the level of KCC2 and corrected the function of the GABA neurotransmitter. IGF1 is a molecule that has been shown to alleviate symptoms in a mouse model of Rett Syndrome and is the subject of an ongoing phase-2 clinical trial for the treatment of the disease in humans.
“The finding that IGF1 can rescue the impaired KCC2 level in Rett neurons is important not only because it provides an explanation for the action of IGF1,” said Xin Tang, a graduate student in Chen’s Lab and the first-listed author of the paper, “but also because it opens the possibility of finding more small molecules that can act on KCC2 to treat Rett syndrome and other autism spectrum disorders.”
Read more:Â Discovery of a new drug target could lead to novel treatment for severe autism
The Latest on: Autism-spectrum disorder
[google_news title=”” keyword=”Autism-spectrum disorder” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autism-spectrum disorder
- What Is the Difference Between ADHD and Autism?on May 17, 2024 at 9:00 am
ADHD and autism are the two most common neurodevelopmental disorders that start in childhood and persist into adulthood. However, they affect you differently.
- Pimavanserin tartrate by Acadia Pharmaceuticals for Autism Spectrum Disorder (ASD): Likelihood of Approvalon May 16, 2024 at 7:07 pm
Pimavanserin tartrate is under clinical development by Acadia Pharmaceuticals and currently in Phase III for Autism Spectrum Disorder (ASD).
- New Autism Study Reveals 'Tantalizing Clues' About Its Developmenton May 16, 2024 at 11:26 am
In a study published in The American Journal of Pathology, Lingyan, Gang and their colleagues investigated the role of dopamine signaling in autism development. "Our quest was to uncover a novel ...
- How to improve social skills in children with autism spectrum disorderon May 16, 2024 at 2:20 am
Developing social skills in children with autism is challenging and an evolving process as the child grows older. Here are tips by expert ...
- Researchers find association of autism spectrum disorder, disrupted developmental dopamineon May 16, 2024 at 1:02 am
According to recent research, dopamine is essential for the growth of neurons. Researchers have shown that autism spectrum disorder (ASD) and disrupted impaired developmental dopamine signalling are ...
- Greenville Detention Officers Undergo Autism crisis intervention trainingon May 15, 2024 at 5:25 pm
The South Carolina Department of Disabilities has joined forces with the Greenville Detention Center to equip officers with a deeper understanding of autism spectrum disorders.
- Psychologists Reveal New Predictor of Autism in 6-Month-Oldson May 15, 2024 at 11:00 am
The findings focus on children who are at a higher risk of developing autistic traits and may support earlier diagnoses for these high-risk groups.
- New study links autism spectrum disorder to disrupted developmental dopamineon May 15, 2024 at 10:22 am
This diagram shows that dopamine regulates neuron specification, suggesting its role in modulating neural circuits during development, potentially contributing to autism spectrum disorder–related ...
- Autism Diagnoses May Be Improved 'Substantially'on May 15, 2024 at 9:15 am
The results could help overcome delays and disparities in diagnoses to allow for early interventions and ultimately reduce lifetime care costs.
- Can robot-inspired computer-assisted therapy benefit children with autism?on May 15, 2024 at 12:10 am
A new study published in the Journal of Computer Assisted Learning introduces a novel robot-inspired computer-assisted adaptive autism therapy (RoboCA3T) that leverages the natural affinity of ...
via Bing News